During the corresponding time, Lemaitre Vascular Inc recorded a revenue increase by 10.02 % year on year, sequentially revenue grew by 6 %. While revenue at the Lemaitre Vascular Inc 's corporate clients
Lemaitre Vascular Inc's Comment on Sales, Marketing and Customers
The company primarily serves vascular surgeons who treat peripheral vascular disease and perform both open vascular surgeries and endovascular procedures. In 2025, approximately 80% of sales were to vascular surgeons, with over 95% of net sales derived from devices used in open surgical procedures, including open vascular and cardiac surgeries. The company also targets adjacent end users such as cardiac surgeons. Sales are conducted mainly through a direct sales force in North America, Europe, and Asia Pacific, with about 95% of net sales generated through direct-to-hospital channels. No single hospital customer accounted for more than 2% of net sales. The company focuses on low-rivalry niche segments with annual worldwide revenues under $400 million and plans to expand its product offerings and technology platforms primarily through acquisitions.
Lemaitre Vascular Inc’s Comment on Sales, Marketing and Customers
The company primarily serves vascular surgeons who treat peripheral vascular disease and perform both open vascular surgeries and endovascular procedures. In 2025, approximately 80% of sales were to vascular surgeons, with over 95% of net sales derived from devices used in open surgical procedures, including open vascular and cardiac surgeries. The company also targets adjacent end users such as cardiac surgeons. Sales are conducted mainly through a direct sales force in North America, Europe, and Asia Pacific, with about 95% of net sales generated through direct-to-hospital channels. No single hospital customer accounted for more than 2% of net sales. The company focuses on low-rivalry niche segments with annual worldwide revenues under $400 million and plans to expand its product offerings and technology platforms primarily through acquisitions.
Sources:
Lemaitre Vascular Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Lemaitre Vascular Inc’s corporate clients.
For your research, we’ve provided 9 tables on Lemaitre Vascular Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
194.56 %